Dr. Jones received his BS from Coppin State University and PhD from Duke University.
The goal of the Jones lab is to identify novel therapeutic targets for mental health disorders. Specifically, we focus on schizophrenia, depression and drug abuse.
Sokolowski, K., Esumi, S., Hirata,T. Kamal, Y., Tran, T., Lam, A., Oboti, L., Brighthaupt, S-C, Zaghlula, M., Martinez, J., Ghimbovschi, S., Knoblach,S., Pierani,A., Tamamaki, N., Shah,N.M., Jones, K.S. and Corbin, J.G. Specification of select hypothalamic circuits and innate behaviors by the embryonic patterning gene Dbx1. Neuron 86 (2):403-16 (2015).
Jones, K.S., Corbin, JC and Huntsman, M.M. Neonatal NMDA Receptor Blockade Disrupts Spike Timing and Glutamatergic Synapses in Fast Spiking Interneurons in a NMDA Receptor Hypofunction Model of Schizophrenia. PLoS.One. Oct 7;9 (10) (2014).
Antoine TE1, Jones KS, Dale RM, Shukla D, Tiwari V. Zebrafish: modeling for herpes simplex virus infections. Zebrafish. 2014 Feb;11(1):17-25. doi: 10.1089/zeb.2013.0920.
Hubbard S, Darmani NA, Thrush GR, Dey D, Burnham L, Thompson JM, Jones KS, Tiwari V. (2010). Zebrafish-Encoded 3-O-Sulfotransferase-3 Isoform Mediates Herpes Simplex Virus Type 1 Entry and Spread. Zebrafish 7: May 2010.
Jones, K.S., Chen, J.C., Patel, R.C., and Friedman, T.C. (2010) The Behavioral and Pharmacological Actions of NMDA Receptor Antagonism are Conserved in Zebrafish Larvae. International Journal of Comparative Psychology 23:82-90.
Jones K.S., Alimov AP, Rilo HL, Jandacek RJ, Woollett LA, Penberthy WT. (2008) A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development. Nutr Metab. 5:23.